1. Home
  2. EPOW vs LSTA Comparison

EPOW vs LSTA Comparison

Compare EPOW & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPOW
  • LSTA
  • Stock Information
  • Founded
  • EPOW 2014
  • LSTA 1980
  • Country
  • EPOW China
  • LSTA United States
  • Employees
  • EPOW N/A
  • LSTA N/A
  • Industry
  • EPOW Business Services
  • LSTA Misc Health and Biotechnology Services
  • Sector
  • EPOW Consumer Discretionary
  • LSTA Health Care
  • Exchange
  • EPOW Nasdaq
  • LSTA Nasdaq
  • Market Cap
  • EPOW N/A
  • LSTA 20.0M
  • IPO Year
  • EPOW 2021
  • LSTA N/A
  • Fundamental
  • Price
  • EPOW $0.88
  • LSTA $1.97
  • Analyst Decision
  • EPOW
  • LSTA Strong Buy
  • Analyst Count
  • EPOW 0
  • LSTA 1
  • Target Price
  • EPOW N/A
  • LSTA $15.00
  • AVG Volume (30 Days)
  • EPOW 30.9K
  • LSTA 10.9K
  • Earning Date
  • EPOW 05-22-2025
  • LSTA 05-08-2025
  • Dividend Yield
  • EPOW N/A
  • LSTA N/A
  • EPS Growth
  • EPOW N/A
  • LSTA N/A
  • EPS
  • EPOW N/A
  • LSTA N/A
  • Revenue
  • EPOW $46,625,085.00
  • LSTA $1,000,000.00
  • Revenue This Year
  • EPOW N/A
  • LSTA N/A
  • Revenue Next Year
  • EPOW N/A
  • LSTA N/A
  • P/E Ratio
  • EPOW N/A
  • LSTA N/A
  • Revenue Growth
  • EPOW N/A
  • LSTA N/A
  • 52 Week Low
  • EPOW $0.53
  • LSTA $1.87
  • 52 Week High
  • EPOW $1.36
  • LSTA $4.20
  • Technical
  • Relative Strength Index (RSI)
  • EPOW 42.73
  • LSTA 32.50
  • Support Level
  • EPOW $0.84
  • LSTA $2.31
  • Resistance Level
  • EPOW $1.05
  • LSTA $2.26
  • Average True Range (ATR)
  • EPOW 0.07
  • LSTA 0.19
  • MACD
  • EPOW -0.01
  • LSTA -0.04
  • Stochastic Oscillator
  • EPOW 21.44
  • LSTA 9.56

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

Share on Social Networks: